Bayer

News

Boundless Bio raises $100m for circular DNA cancer therapy

Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising

News

Astellas breaks new ground in menopause with Veozah

Astellas has become the first drugmaker to bring a drug in the neurokinin 3 (NK3) receptor antagonist class to the US market, after getting FDA approval of fezolinetant fo

R&D

Bayer’s bet on CGT: Casting a wide net for innovation

With the opening of Co.Labs, Bayer's flagship coworking space for biotech start-ups in CGT, the company looks to cast a wide net for external and internal innovation in the emerging space.

News

Bayer adds US life sciences incubator in Cambridge

Bayer has formally opened a new life sciences incubator in Cambridge, Massachusetts, that will focus on cell and gene therapies (CGT).

News

Digital tech assessed in BlueRock Parkinson’s trial

Devices that remotely monitor patients' mobility and sleep will be put through their paces.

Digital

Health Innovators – Nigel Brokenshire

At the HealthTech X Digitisation of Pharma summit in London in February, pharmaphorum editor-in-chief Jonah Comstock grabbed Nigel Brokenshire, director of UK digital for Bayer, for a quick intervi

Boundless Bio raises $100m for circular DNA cancer therapy

Astellas breaks new ground in menopause with Veozah

Bayer’s bet on CGT: Casting a wide net for innovation

Bayer adds US life sciences incubator in Cambridge

Digital tech assessed in BlueRock Parkinson’s trial

Health Innovators – Nigel Brokenshire

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

Bayer

Editor's Picks